Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB26FFWVR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,429
Award facts
- Contract value 100% obligated
- $15,428.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,428.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a completion deadline of November 4, 2025. The contract, awarded November 3, 2025, utilized no set-aside designation and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains a comprehensive IDC valued at $999,999,999.00 through December 2026 that enables delivery of pharmaceutical products and medical supplies across multiple therapeutic domains globally.
This delivery order falls under AmerisourceBergen Drug Corp's broader pharmaceutical prime vendor arrangement with DLA Troop Support Medical, which supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Repatha (evolocumab), a PCSK9 inhibitor used for cardiovascular disease management, represents the specialized medication category that AmerisourceBergen regularly supplies through its federal contracts. The company's portfolio demonstrates consistent capability in fulfilling competitively awarded federal medical supply requirements across varying transaction values, from small orders to substantial procurements exceeding $45,000.
Quick answers
Who was awarded contract SPE2DB26FFWVR?
SPE2DB26FFWVR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FFWVR worth?
The government has obligated $15,429 on SPE2DB26FFWVR.
Is contract SPE2DB26FFWVR an order under another contract?
Yes. SPE2DB26FFWVR is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB26FFWVR competed?
The extent of competition for SPE2DB26FFWVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award